Home/Filings/4/0001209191-11-036896
4//SEC Filing

Bradford Williamson Z III 4

Accession 0001209191-11-036896

CIK 0001087432other

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 3:57 PM ET

Size

8.5 KB

Accession

0001209191-11-036896

Insider Transaction Report

Form 4
Period: 2011-06-29
Bradford Williamson Z III
SVP-Clinical Science
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2011-06-296,0000 total
    Exercise: $12.74Exp: 2015-06-24Common Stock (6,000 underlying)
  • Exercise/Conversion

    Common Stock

    2011-06-29$12.74/sh+6,000$76,44067,577 total
  • Sale

    Common Stock

    2011-06-29$35.47/sh6,000$212,83661,577 total
Footnotes (3)
  • [F1]These transactions were made pursuant to a 10b5-1 trading plan entered into in the fourth quarter of 2010 and in effect at the time of the transactions. The transactions were pre-determined in the trading plan to occur at specific dates and share prices of InterMune.
  • [F2]Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $35.28 to $35.61 per share. Full information on the numbers of shares sold at each sale price is available upon request.
  • [F3]Fully exercisable.

Issuer

INTERMUNE INC

CIK 0001087432

Entity typeother

Related Parties

1
  • filerCIK 0001306194

Filing Metadata

Form type
4
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 3:57 PM ET
Size
8.5 KB